Previous Article | Next Article 
Infection and Immunity, August 2000, p. 4778-4781, Vol. 68, No. 8
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
[Cu,Zn]-Superoxide Dismutase Mutants of the Swine
Pathogen Actinobacillus pleuropneumoniae Are
Unattenuated in Infections of the Natural Host
Brian J.
Sheehan,1
Paul R.
Langford,1
Andrew N.
Rycroft,2 and
J. Simon
Kroll1,*
Molecular Infectious Diseases Group, Department of
Paediatrics, Imperial College School of Medicine, St. Mary's Campus,
London W2 1PG,1 and Department of
Pathology and Infectious Diseases, The Royal Veterinary College,
University of London, North Mymms, Hatfield, Hertfordshire AL9
7TA,2 United Kingdom
Received 31 January 2000/Returned for modification 17 April
2000/Accepted 1 May 2000
 |
ABSTRACT |
Actinobacillus pleuropneumoniae, the causative agent of
porcine pleuropneumonia, contains a periplasmic Cu- and Zn-cofactored superoxide dismutase ([Cu,Zn]-SOD, or SodC) which has the potential, realized in other pathogens, to promote bacterial survival during infection by dismutating host-defense-derived superoxide. Here we
describe the construction of a site-specific, [Cu,Zn]-SOD-deficient A. pleuropneumoniae serotype 1 mutant and show that
although the mutant is highly sensitive to the microbicidal action of
superoxide in vitro, it remains fully virulent in experimental
pulmonary infection in pigs.
 |
TEXT |
The gram-negative bacterium
Actinobacillus pleuropneumoniae causes porcine
pleuropneumonia, a highly contagious infection of pigs that is
responsible for substantial economic losses worldwide. First described
in 1957, A. pleuropneumoniae infection has become more
frequent in recent years, particularly where animals are subjected to
intensive breeding conditions (29, 33). Infection is highly
host specific, and organisms spread from one animal to another via
respiratory droplets (27, 33). The disease is characterized
by increasingly severe pulmonary distress leading to death after 24 to
48 h or to chronic infection resulting in a failure to thrive
(14, 33). No effective vaccine strategy has yet been devised
to prevent infection. In the process of elucidating the sequence of
critical interactions between organism and host that lead to severe
disease, capsule, lipopolysaccharide, RTX-like toxins (ApxI to
ApxIVA), lipoproteins, secreted proteases, and superoxide dismutase
(SOD) have been identified as potential determinants of virulence
(9, 12, 18, 26, 28, 32). This defines at once the potential
of purified gene products or knockout mutant A. pleuropneumoniae strains for use as subunit or live-attenuated vaccines, respectively, and the recent development of genetic systems
for A. pleuropneumoniae (15, 25, 37, 40) now
allows these possibilities to be formally investigated.
The gene sodC, which encodes the copper- and zinc-cofactored
SOD ([Cu,Zn]-SOD) of A. pleuropneumoniae, was previously
identified, cloned, and sequenced in this laboratory (17,
18). SODs are metalloproteins that catalyze the dismutation of
the highly reactive superoxide radical anion to hydrogen peroxide and
oxygen (22). This is the first step in a series of reactions
which prevent the accumulation of cytotoxic oxygen free radicals and
nitrogen free radicals generated by the reduction of molecular oxygen. SODs are classified according to the metalloprotein at their active site, and three major forms have been identified in bacteria. Iron- and
manganese-cofactored SODs are located in the cytoplasm and serve to
remove superoxide anions generated during the course of aerobic
respiration (10). In contrast, in all cases where location
has been determined experimentally, bacterial [Cu,Zn]-SODs have been
shown to be periplasmic (18; reference
31 and references therein). As superoxide is unable
to cross the cytoplasmic membrane (13), it has been
suggested that [Cu,Zn]-SOD provides protection from superoxide
generated outside the cell. During the course of infection, many
bacterial pathogens are exposed to high levels of activated oxygen
species generated by inflammatory cells during the respiratory burst.
The theoretical capacity of bacterial [Cu,Zn]-SODs to dismutate
exogenous superoxide suggests a role for these enzymes in pathogenesis.
In support of this hypothesis, Neisseria meningitidis and
Salmonella enterica serovar Typhimurium strains
deficient in [Cu,Zn]-SOD production are attenuated in the mouse model
of infection (5, 8, 41). However, the picture is not
clear-cut. For example, two groups have presented conflicting evidence
for the role of [Cu,Zn]-SOD in the growth and multiplication of
Brucella abortus in BALB/c mice (19, 38). To
investigate the role of [Cu,Zn]-SOD in the pathogenesis of A. pleuropneumoniae infection and to assess the live-vaccine
potential of a [Cu,Zn]-SOD-deficient mutant, we have constructed a
sodC mutant of A. pleuropneumoniae strain 4074 by
allele exchange. We investigated the impact of this mutation on
virulence in experimental infections of the natural host, the pig.
Construction of A. pleuropneumoniae sodC mutant.
The cloned sodC gene was interrupted by the insertion of a
kanamycin resistance cassette (Kanr) at the unique
EcoNI site located 144 bp downstream from the sodC initiation codon. Briefly, a 3.4-kb
EcoRI-EcoRV fragment containing A. pleuropneumoniae sodC was excised from pJSK150 (18) and
cloned into pBluescript to generate plasmid pJSK155. A 1.3-kb HincII fragment containing Kanr from plasmid
pB16 (pB16 is a precursor to pB51 [35] and contains the Tn903 Kanr gene flanked on either side by a
polylinker containing various restriction sites including the
HincII site) was then cloned into pJSK155 that had been
linearized with EcoNI and Klenow treated to generate
blunt ends. The resultant plasmid, designated pJSK333, was
transferred into A. pleuropneumoniae strain 4074 (serotype 1) by electroporation (15, 24). As the ColE1 origin of
plasmid pJSK333 does not function in A. pleuropneumoniae,
kanamycin-resistant transformants can only arise following
recombination between the mutant sodC allele and wild-type
sodC sequences by single or double crossover. After 48 h of growth, three kanamycin-resistant transformants were isolated on
selective brain heart infusion plates supplemented with 10%
Levinthal's base (1). Southern blot and PCR analysis with
sodC-specific oligonucleotide primers demonstrated that in all cases the mutant sodC::Kan allele had replaced
the wild-type sodC gene on the chromosome in a double
crossover event (data not shown). As sodC is expressed as a
monocistronic unit (21), insertion of the antibiotic
cassette would not be expected to exert a polar effect on the activity
of neighboring genes. One isolate, SK564, was used in subsequent experiments.
SOD expression in wild type and sodC mutants of
A. pleuropneumoniae.
To verify that [Cu,Zn]-SOD production
was abrogated in strain SK564, wild-type and SK564 mutant strains were
grown aerobically in liquid culture until the stationary phase of
growth. Whole-cell sonicates were separated electrophoretically on
nondenaturing gels and stained for SOD activity as described previously
(18). Two bands of SOD activity were observed when wild-type
A. pleuropneumoniae was grown under nutrient-replete,
aerobic conditions (Fig. 1) (17). Mn-SOD activity, manifested as a diffuse, achromatic
zone at a position of relatively high mobility, was present in both wild-type and SK564 mutant extracts (Fig. 1, lanes 1 and 2). In contrast, [Cu,Zn]-SOD activity was present only in wild-type extracts (the prominent achromatic band in Fig. 1, lane 1) and was absent from
extracts derived from the sodC::Kan strain, SK564
(Fig. 1, lane 2).

View larger version (83K):
[in this window]
[in a new window]
|
FIG. 1.
SOD activity of whole-cell sonicates of A. pleuropneumoniae strains 4074 (wild type, lane 1) and SK564
(sodC::Kan, lane 2). Each lane contained
approximately 40 µg of total protein. [Cu,Zn]-SOD activity in the
wild-type extract is indicated by the arrow. The more diffuse Mn-SOD
activity, present in both lanes, is indicated by the dashed line.
|
|
Effect of sodC mutation on susceptibility to exogenous
superoxide in vitro.
The A. pleuropneumoniae wild type
and sodC mutant strain SK564 were exposed to exogenous
superoxide generated by the oxidation of xanthine as described
previously (8). Production of superoxide in solution was
initiated by the addition of 0.1 U of xanthine oxidase/ml, and
bacterial survival was monitored by estimation of viable counts at
hourly intervals over a 3-h period. The viability of wild-type A. pleuropneumoniae was unaffected by superoxide in vitro (100%
survival or greater) (Fig. 2). In
contrast, sodC mutant bacteria were highly susceptible to
the microbicidal action of superoxide; 99% of mutant bacteria were
killed after 3 h of incubation in the presence of xanthine oxidase
(Fig. 2). Thus, the A. pleuropneumoniae [Cu,Zn]-SOD plays
a crucial role in the detoxification of exogenously generated
superoxide, allowing bacteria to survive challenge with superoxide in
vitro. These results are comparable to those obtained with other
organisms; Salmonella serovar Typhimurium and N. meningitidis mutants lacking [Cu,Zn]-SOD were strikingly more
susceptible than otherwise isogenic wild-type bacteria to superoxide
generated in solution by the xanthine-xanthine oxidase system (5,
8, 41).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
Effect of the sodC mutation on survival of
A. pleuropneumoniae exposed to superoxide in vitro. Survival
of wild type bacteria (squares) and sodC mutant bacteria
(circles) in phosphate-buffered saline with 0.1 mM xanthine (open
symbols) and in phosphate-buffered saline with 0.1 mM xanthine and 0.1 U of xanthine oxidase/ml (filled symbols) is shown. Data (means and
ranges for duplicate experiments) are percentages of the starting cell
density (range, 1 × 108 to 2.5 × 108 CFU/ml).
|
|
Virulence of SodC-defective A. pleuropneumoniae.
In the
cases of Salmonella serovar Typhimurium and N. meningitidis sodC mutants, susceptibility to exogenous superoxide
in vitro correlates with susceptibility to killing by
superoxide-mediated host defense mechanisms and to attenuation of
virulence in mouse models of infection (5, 8, 41). As
challenge with A. pleuropneumoniae is known to elicit a
vigorous respiratory burst of oxygen free radical production from
porcine neutrophils (7), we investigated the effect of
sodC mutation on the course of A. pleuropneumoniae infection in the natural (porcine) host. Two
groups of seven 4-week-old, conventionally weaned piglets determined to
be A. pleuropneumoniae free by bacteriological and
serological analyses were inoculated intratracheally (30)
with a range of doses of either strain 4074 (group B) or strain SK564
(group A), as detailed in Table 1. No
significant difference was seen at any dose. Both animals receiving the
high dose (ca. 2 × 107 CFU) and one of two animals
given the intermediate dose (ca. 2 × 105 CFU) but no
animal given the low dose (ca. 4 × 103 CFU) in group
A or B developed clinical signs of respiratory disease within 36 h
(Table 1). Surviving animals were euthanized after 42 h.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Virulence of wild type (strain 4074) and
sodC::Kan mutant (strain SK564) of A. pleuropneumoniae in experimental porcine infection
|
|
Hemorrhagic pulmonary lesions and fibrinous pleurisy typical of
A. pleuropneumoniae infection were demonstrated in all
animals
showing clinical signs of disease. The reisolation of
A. pleuropneumoniae confirmed the etiology of the lesions in each
case (Table
1),
and the identity of the bacterial isolates as the
mutant or wild-type
strain was confirmed by PCR establishing the
absence (wild type)
or presence (mutant) of the Kan
r
cassette (data not shown). No lesions were observed in animals
without
clinical signs, and no bacteria were recovered from the
lungs of these
animals. The pathology of the lesions in pigs infected
with the
sodC mutant strain was indistinguishable from that of
lesions caused by the parent strain, 4074, with extensive infiltration
of alveolar spaces by inflammatory cells and areas of edema, fibrinous
exudate, and hemorrhage (data not shown). Thus, in contrast to
results
for
Salmonella serovar Typhimurium and
N. meningitidis
and
despite a demonstrable, pivotal role of
[Cu,Zn]-SOD in resistance
to exogenous superoxide in vitro

we could
not identify a clinically
significant role for [Cu,Zn]-SOD in the
pathogenesis of
A. pleuropneumoniae infection.
Plainly, a
sodC mutant of otherwise wild-type
A. pleuropneumoniae that retains wild-type virulence would not be
suitable as
a live vaccine strain to prevent porcine pleuropneumonia.
We infer
from the contrast between the unimpaired virulence of a
sodC-defective
strain of
A. pleuropneumoniae and
the attenuation of corresponding
mutants of
Salmonella
serovar Typhimurium and
N. meningitidis a fundamental
difference in the way that these pathogens interact
with phagocytic
cells.
A. pleuropneumoniae causes disease predominantly as an
extracellular pathogen, with little evidence for a significant
intracellular
phase (
3,
6). Pulmonary defense against
A. pleuropneumoniae is mediated by resident alveolar
macrophages and by migratory
neutrophils that are recruited to the lung
alveoli as early as
3 h after the onset of infection (
20,
34). Although infection
elicits a vigorous neutrophil and
alveolar macrophage response
in vitro with a substantial respiratory
burst of oxygen free-radical
production (
7), these cells are
rapidly killed by the bacteria.
This toxicity is principally mediated
by the secreted bacterial
cytolytic toxins ApxI and ApxII (
3,
15,
39), toxins which
also inhibit neutrophil chemotaxis and
phagocytosis (
36). Only
in the absence of Apx toxins or in
the presence of convalescent-stage
pig serum are significant numbers of
A. pleuropneumoniae internalized
by neutrophils, and
evidence suggests that once internalized the
bacteria are rapidly
killed (
2,
3). Thus, while our in vitro
data demonstrate the
potential for [Cu,Zn]-SOD to facilitate bacterial
survival in an
oxygen free radical-rich environment, this survival
mechanism appears
to be redundant (at least during acute experimental
infection) in the
presence of the potent Apx toxins. In contrast,
the pathogenetic
sequence of infection with either
N. meningitidis or
Salmonella serovar Typhimurium includes subversion of the
antibacterial
action of phagocytic cells and their colonization rather
than
destruction, in a necessary prelude to tissue invasion and/or
chronic intracellular infection (
16,
23). In these
circumstances,
it seems plausible that bacterial [Cu,Zn]-SOD may play
a more
critical role in the interactive biology of host and
pathogen.
 |
ACKNOWLEDGMENTS |
This work was supported by grants from the Meningitis Research
Foundation, the Biotechnology and Biological Sciences Research Council,
and the Wellcome Trust.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Molecular
Infectious Diseases Group, Department of Paediatrics, Imperial College
School of Medicine, St. Mary's Campus, London W2 1PG, United Kingdom. Phone: 020 7886 6220. Fax: 020 7886 6284. E-mail:
s.kroll{at}ic.ac.uk.
Editor:
J. T. Barbieri
 |
REFERENCES |
| 1.
|
Alexander, H. E.
1965.
The Haemophilus group, p. 724-741.
In
R. J. Dubosand, and J. G. Hirdch (ed.), Bacterial and mycotic infections of man. Pittman Medical Publishing Co., London, England.
|
| 2.
|
Cruijsen, T. L. M.,
L. A. M. G. Van Leengoed,
T. C. E. M. Dekker-Nooren,
E. J. Schoevers, and J. H. M. Verheijden.
1992.
Phagocytosis and killing of Actinobacillus pleuropneumoniae by alveolar macrophages and polymorphonuclear leukocytes isolated from pigs.
Infect. Immun.
60:4867-4871[Abstract/Free Full Text].
|
| 3.
|
Cullen, J. M., and A. N. Rycroft.
1994.
Phagocytosis by pig alveolar macrophages of Actinobacillus pleuropneumoniae serotype 2 mutant strains defective in haemolysin II (ApxII) and pleurotoxin (ApxIII).
Microbiology
140:237-244[Abstract/Free Full Text].
|
| 4.
|
Davis, B. J.
1964.
Disc electrophoresis. II. Method and application to human serum proteins.
Ann. N. Y. Acad. Sci.
121:404-427.
|
| 5.
|
De Groote, M. A.,
U. A. Ochsner,
M. U. Shiloh,
C. Nathan,
J. M. McCord,
M. C. Dinauer,
S. J. Libby,
A. Vazquez-Torres,
Y. Xu, and F. C. Fang.
1997.
Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase.
Proc. Natl. Acad. Sci. USA
94:13997-14001[Abstract/Free Full Text].
|
| 6.
|
Dom, P.,
F. Haesebrouck,
R. Ducatelle, and G. Charlier.
1994.
In vivo association of Actinobacillus pleuropneumoniae serotype 2 with the respiratory epithelium of pigs.
Infect. Immun.
62:1262-1267[Abstract/Free Full Text].
|
| 7.
|
Dom, P.,
F. Haesebrouck,
E. M. Kamp, and M. A. Smits.
1992.
Influence of Actinobacillus pleuropneumoniae serotype 2 and its cytolysins on porcine neutrophil chemiluminescence.
Infect. Immun.
60:4328-4334[Abstract/Free Full Text].
|
| 8.
|
Farrant, J. L.,
A. Sansone,
J. R. Canvin,
M. J. Pallen,
P. R. Langford,
T. S. Wallis,
G. Dougan, and J. S. Kroll.
1997.
Bacterial copper- and zinc-cofactored superoxide dismutase contributes to the pathogenesis of systemic salmonellosis.
Mol. Microbiol.
25:785-796[CrossRef][Medline].
|
| 9.
|
Frey, J.
1995.
Virulence in Actinobacillus pleuropneumoniae and RTX toxins.
Trends Microbiol.
3:257-261[CrossRef][Medline].
|
| 10.
|
Fridovich, I.
1995.
Superoxide radical and superoxide dismutases.
Annu. Rev. Biochem.
64:97-112[CrossRef][Medline].
|
| 11.
|
Fuller, T. E.,
B. J. Thacker, and M. H. Mulks.
1996.
A riboflavin auxotroph of Actinobacillus pleuropneumoniae is attenuated in swine.
Infect. Immun.
64:4659-4664[Abstract].
|
| 12.
|
Gerlach, G.-F.,
C. Anderson,
S. Klashinsky,
A. Rossi-Campos,
A. A. Potter, and P. J. Willson.
1993.
Molecular characterization of a protective outer membrane lipoprotein (OmlA) from Actinobacillus pleuropneumoniae serotype 1.
Infect. Immun.
61:565-572[Abstract/Free Full Text].
|
| 13.
|
Hassan, H. M., and I. Fridovich.
1979.
Paraquat and Escherichia coli. Mechanism of production of extracellular superoxide radical.
J. Biol. Chem.
254:10846-10852[Abstract/Free Full Text].
|
| 14.
|
Inzana, T. J.
1991.
Virulence properties of Actinobacillus pleuropneumoniae.
Microb. Pathog.
11:305-316[CrossRef][Medline].
|
| 15.
|
Jansen, R.,
J. Briaire,
H. E. Smith,
P. Dom,
F. Haesebrouck,
E. M. Kamp,
A. L. Gielkens, and M. A. Smits.
1995.
Knockout mutants of Actinobacillus pleuropneumoniae serotype 1 that are devoid of RTX toxins do not activate or kill porcine neutrophils.
Infect. Immun.
63:27-37[Abstract].
|
| 16.
|
Jones, B. D., and S. Falkow.
1996.
Salmonellosis: host immune responses and bacterial virulence determinants.
Annu. Rev. Immunol.
14:533-561[CrossRef][Medline].
|
| 17.
|
Kroll, J. S.,
P. R. Langford,
K. E. Wilks, and A. D. Keil.
1995.
Bacterial [Cu,Zn]-superoxide dismutase: phylogenetically distinct from the eukaryotic enzyme, and not so rare after all!
Microbiology
141:2271-2279[Abstract/Free Full Text].
|
| 18.
|
Langford, P. R.,
B. M. Loynds, and J. S. Kroll.
1996.
Cloning and molecular characterization of Cu,Zn superoxide dismutase from Actinobacillus pleuropneumoniae.
Infect. Immun.
64:5035-5041[Abstract].
|
| 19.
|
Latimer, E.,
J. Simmers,
N. Sriranganathan,
R. M. Roop II,
G. G. Schurig, and S. M. Boyle.
1992.
Brucella abortus deficient in copper/zinc superoxide dismutase is virulent in BALB/c mice.
Microb. Pathog.
12:105-113[CrossRef][Medline].
|
| 20.
|
Liggett, A. D.,
L. R. Harrison, and R. L. Farrell.
1987.
Sequential study of lesion development in experimental haemophilus pleuropneumonia.
Res. Vet. Sci.
42:204-221[Medline].
|
| 21.
|
Loynds, B. M.,
P. R. Langford, and J. S. Kroll.
1992.
recF in Actinobacillus pleuropneumoniae.
Nucleic Acids Res.
20:615[Free Full Text].
|
| 22.
|
McCord, J. M., and I. Fridovich.
1969.
Superoxide dismutase. An enzymatic function for erythrocuprein (hemocuprein).
J. Biol. Chem.
244:6049-6055[Abstract/Free Full Text].
|
| 23.
|
McNeil, G.,
M. Virji, and E. R. Moxon.
1994.
Interactions of Neisseria meningitidis with human monocytes.
Microb. Pathog.
16:153-163[CrossRef][Medline].
|
| 24.
|
Miller, J. F.,
W. J. Dower, and L. S. Tompkins.
1988.
High-voltage electroporation of bacteria: genetic transformation of Campylobacter jejuni with plasmid DNA.
Proc. Natl. Acad. Sci. USA
85:856-860[Abstract/Free Full Text].
|
| 25.
|
Mulks, M. H., and J. M. Buysse.
1995.
A targeted mutagenesis system for Actinobacillus pleuropneumoniae.
Gene
165:61-66[CrossRef][Medline].
|
| 26.
|
Negrete-Abascal, E.,
V. R. Tenorio,
J. J. Serrano,
C. Garcia, and M. de la Garza.
1994.
Secreted proteases from Actinobacillus pleuropneumoniae serotype 1 degrade porcine gelatin, hemoglobin and immunoglobulin A.
Can. J. Vet. Res.
58:83-86[Medline].
|
| 27.
|
Nicolet, J.
1992.
Actinobacillus pleuropneumoniae, p. 401-408.
In
A. D. Leaman, B. E. Straw, S. Mengeling, S. D'Allaire, and D. J. Taylor (ed.), Diseases of swine. Iowa State University Press, Ames.
|
| 28.
|
Paradis, S.-E.,
D. Dubreuil,
S. Rioux,
M. Gottschalk, and M. Jacques.
1994.
High-molecular-mass lipopolysaccharides are involved in Actinobacillus pleuropneumoniae adherence to porcine respiratory tract cells.
Infect. Immun.
62:3311-3319[Abstract/Free Full Text].
|
| 29.
|
Pattison, I. H.,
D. G. Howell, and J. Elliot.
1957.
A Haemophilus-like organism isolated from pig lung and the associated pneumonic lesions.
J. Comp. Pathol.
67:320-329[Medline].
|
| 30.
|
Rycroft, A. N.,
D. Williams,
I. A. McCandlish, and D. J. Taylor.
1991.
Experimental reproduction of acute lesions of porcine pleuropneumonia with a haemolysin-deficient mutant of Actinobacillus pleuropneumoniae.
Vet. Rec.
16:441-443.
|
| 31.
|
San Mateo, L. R.,
M. M. Hobbs, and T. H. Kawula.
1998.
Periplasmic copper-zinc superoxide dismutase protects Haemophilus ducreyi from exogenous superoxide.
Mol. Microbiol.
27:391-404[CrossRef][Medline].
|
| 32.
|
Schaller, A.,
R. Khun,
P. Kuhnert,
J. Nicolet,
T. J. Anderson,
J. I. MacInnes,
R. P. A. M. Segers, and J. Frey.
1999.
Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae.
Microbiology
145:2105-2116[Abstract/Free Full Text].
|
| 33.
|
Sebunya, T. N. K., and J. R. Saunders.
1983.
Haemophilus pleuropneumoniae infections in swine: a review.
J. Am. Vet. Med. Assoc.
182:1331-1337[Medline].
|
| 34.
|
Sibille, Y., and H. Y. Reynolds.
1990.
Macrophages and polymorphonuclear neutrophils in lung defense and injury.
Am. Rev. Respir. Dis.
141:471-501[Medline].
|
| 35.
|
Szabo, M.,
D. Maskell,
P. Butler,
J. Love, and R. Moxon.
1992.
Use of chromosomal gene fusions to investigate the role of repetitive DNA in regulation of genes involved in lipopolysaccharide biosynthesis in Haemophilus influenzae.
J. Bacteriol.
174:7245-7252[Abstract/Free Full Text].
|
| 36.
|
Tarigan, S.,
R. F. Slocombe,
G. F. Browning, and W. Kimpton.
1994.
Functional and structural changes of porcine alveolar macrophages induced by sublytic doses of a heat-labile, hemolytic, cytotoxic substance produced by Actinobacillus pleuropneumoniae.
Am. J. Vet. Res.
55:1548-1557[Medline].
|
| 37.
|
Tascon, R. I.,
J. A. Vazquez-Boland,
C. B. Gutierrez,
J. I. Rodriguez-Barbosa, and E. F. Rodriguez-Ferri.
1994.
The RTX haemolysins ApxI and ApxII are major virulence factors of the swine pathogen Actinobacillus pleuropneumoniae: evidence from mutational analysis.
Mol. Microbiol.
14:207-216[CrossRef][Medline].
|
| 38.
|
Tatum, F. M.,
P. G. Detilleux,
J. M. Sacks, and S. M. Halling.
1992.
Construction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice.
Infect. Immun.
60:2863-2869[Abstract/Free Full Text].
|
| 39.
|
Udeze, F. A., and S. Kadis.
1992.
Effects of Actinobacillus pleuropneumoniae hemolysin on porcine neutrophil function.
Infect. Immun.
60:1558-1567[Abstract/Free Full Text].
|
| 40.
|
Ward, C. K.,
M. L. Lawrence,
H. P. Veit, and T. J. Inzana.
1998.
Cloning and mutagenesis of a serotype-specific DNA region involved in encapsulation and virulence of Actinobacillus pleuropneumoniae serotype 5a: concomitant expression of serotype 5a and 1 capsular polysaccharides in recombinant A. pleuropneumoniae serotype 1.
Infect. Immun.
66:3326-3336[Abstract/Free Full Text].
|
| 41.
|
Wilks, K. E.,
K. L. R. Dunn,
J. L. Farrant,
K. M. Reddin,
A. R. Gorringe,
P. R. Langford, and J. S. Kroll.
1998.
Periplasmic superoxide dismutase in meningococcal pathogenicity.
Infect. Immun.
66:213-217[Abstract/Free Full Text].
|
Infection and Immunity, August 2000, p. 4778-4781, Vol. 68, No. 8
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Auger, E., Deslandes, V., Ramjeet, M., Contreras, I., Nash, J. H. E., Harel, J., Gottschalk, M., Olivier, M., Jacques, M.
(2009). Host-Pathogen Interactions of Actinobacillus pleuropneumoniae with Porcine Lung and Tracheal Epithelial Cells. Infect. Immun.
77: 1426-1441
[Abstract]
[Full Text]
-
Balashova, N. V., Park, D. H., Patel, J. K., Figurski, D. H., Kachlany, S. C.
(2007). Interaction between Leukotoxin and Cu,Zn Superoxide Dismutase in Aggregatibacter actinomycetemcomitans. Infect. Immun.
75: 4490-4497
[Abstract]
[Full Text]
-
Keith, K. E., Valvano, M. A.
(2007). Characterization of SodC, a Periplasmic Superoxide Dismutase from Burkholderia cenocepacia. Infect. Immun.
75: 2451-2460
[Abstract]
[Full Text]
-
Fung, W. W. M., O'Dwyer, C. A., Sinha, S., Brauer, A. L., Murphy, T. F., Kroll, J. S., Langford, P. R.
(2006). Presence of Copper- and Zinc-Containing Superoxide Dismutase in Commensal Haemophilus haemolyticus Isolates Can Be Used as a Marker To Discriminate Them from Nontypeable H. influenzae Isolates. J. Clin. Microbiol.
44: 4222-4226
[Abstract]
[Full Text]
-
Beddek, A. J., Sheehan, B. J., Bosse, J. T., Rycroft, A. N., Kroll, J. S., Langford, P. R.
(2004). Two TonB Systems in Actinobacillus pleuropneumoniae: Their Roles in Iron Acquisition and Virulence. Infect. Immun.
72: 701-708
[Abstract]
[Full Text]
-
Bong, C. T. H., Fortney, K. R., Katz, B. P., Hood, A. F., Mateo, L. R. S., Kawula, T. H., Spinola, S. M.
(2002). A Superoxide Dismutase C Mutant of Haemophilus ducreyi Is Virulent in Human Volunteers. Infect. Immun.
70: 1367-1371
[Abstract]
[Full Text]
-
Sansone, A., Watson, P. R., Wallis, T. S., Langford, P. R., Kroll, J. S.
(2002). The role of two periplasmic copper- and zinc-cofactored superoxide dismutases in the virulence of Salmonella choleraesuis. Microbiology
148: 719-726
[Abstract]
[Full Text]
-
Piddington, D. L., Fang, F. C., Laessig, T., Cooper, A. M., Orme, I. M., Buchmeier, N. A.
(2001). Cu,Zn Superoxide Dismutase of Mycobacterium tuberculosis Contributes to Survival in Activated Macrophages That Are Generating an Oxidative Burst. Infect. Immun.
69: 4980-4987
[Abstract]
[Full Text]
-
Baltes, N., Tonpitak, W., Gerlach, G.-F., Hennig-Pauka, I., Hoffmann-Moujahid, A., Ganter, M., Rothkotter, H.-J.
(2001). Actinobacillus pleuropneumoniae Iron Transport and Urease Activity: Effects on Bacterial Virulence and Host Immune Response. Infect. Immun.
69: 472-478
[Abstract]
[Full Text]
-
Battistoni, A., Pacello, F., Mazzetti, A. P., Capo, C., Kroll, J. S., Langford, P. R., Sansone, A., Donnarumma, G., Valenti, P., Rotilio, G.
(2001). A Histidine-rich Metal Binding Domain at the N Terminus of Cu,Zn-Superoxide Dismutases from Pathogenic Bacteria. A NOVEL STRATEGY FOR METAL CHAPERONING. J. Biol. Chem.
276: 30315-30325
[Abstract]
[Full Text]